(Q36402853)

14 August 2017

1 reference

title

Effects in skeletal muscle (English)

1 reference

14 August 2017

Andrew Young

1

1 reference

14 August 2017

publication date

1 January 2005

1 reference

14 August 2017

published in

Advances in Pharmacology

1 reference

14 August 2017

volume

52

1 reference

14 August 2017

page(s)

209-228

1 reference

Calcitonin gene-related peptide stimulates active Na(+)-K+ transport in rat soleus muscle

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Hypertrophic effects of calcitonin gene-related peptide (CGRP) and amylin on adult mammalian ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Glycogen synthase and phosphorylase activities in skeletal muscle from genetically diabetic (db/db) mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Islet amyloid polypeptide decreases the effects of insulin-like growth factor-I on glucose transport and glycogen synthesis in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Effect of amylin and calcitonin gene-related peptide on insulin-stimulated glucose and calcium transport in the diaphragm

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

The effect of amylin and calcitonin gene-related peptide on insulin-stimulated glucose transport in the diaphragm.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Direct observation of glycogen synthesis in human muscle with 13C NMR

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Suppression of insulin-stimulated glucose transport in L6 myocytes by calcitonin gene-related peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

The role of amylin in the insulin resistance of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Effect of synthetic human amylin on glycogen synthesis in skeletal muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Alteration of glycogen synthase activation by insulin in soleus muscles of obese mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Human alpha-calcitonin gene-related peptide-(8-37) as an antagonist of exogenous and endogenous calcitonin gene-related peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Insulin resistance and Na+/K+-ATPase in hypertensive women: a difference in mechanism depending on the level of glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

13C/31P NMR studies on the mechanism of insulin resistance in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Dose-dependent elevation of cyclic AMP, activation of glycogen phosphorylase, and release of lactate by amylin in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Amylin and epinephrine have no direct effect on glucose transport in isolated rat soleus muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

N.m.r. studies of muscle glycogen synthesis in normal and non-insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Cyclic AMP and free fatty acids in the longer-term regulation of pyruvate dehydrogenase kinase in rat soleus muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Lactate production from the rat hindlimb is increased after glucose administration and is suppressed by a selective amylin antagonist: evidence for action of endogenous amylin in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Amylin activates glycogen phosphorylase in the isolated soleus muscle of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Evidence for release of free glucose from muscle during amylin-induced glycogenolysis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in in vitro incubated human muscle strips.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2952011-8

7 January 2021

10.1016/S1054-3589(05)52011-8

Identifiers

DOI

1 reference

14 August 2017

1 reference